WebThe FlowTriever2®catheter is intended for use in the peripheral vasculature. The FlowSaver blood return system is used with Triever catheters for autologous blood transfusion. The FlowStasis®device is intended for temporary suture retention following a percutaneous venous procedure. WebInari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. ... FlowStasis, a large ...
Inari Medical to Announce First Quarter 2024 Financial Results
WebThe FlowSaver is compatible with Triever Catheters and includes a 40 micron filtration system, a clot reservoir, and a 60cc collection syringe. The accessible filtration design allows for clot examination and reservoir cleaning for more filtrations. Filtered blood can be reintroduced using a standard luer lock with the 60cc collection syringe. WebApr 12, 2024 · Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. ... FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture … fixed currency advantage
Inari Medical on Twitter: "#FlowStasis is the 1st large bore suture ...
WebJun 17, 2024 · “#FlowStasis is the 1st large bore suture retention device to address all aspects of venous access site closure. Designed to quickly achieve patent hemostasis by closing the soft tissue tract, FlowStasis eliminates … WebDec 1, 2024 · Inari Medical, Inc. › Flowstasis Application #90350841 Application Filed: 2024-12-01 Trademark Application Details Mark For: FLOWSTASIS® trademark registration is intended to cover the category of medical devices for obtaining hemostasis of percutaneous wounds. [all] Status 2024-07-15 UTC Refresh LIVE APPLICATION Under Examination WebOct 5, 2024 · FlowStasis represents a simple and consistent method of tensioning the compression stitch often used to attain hemostasis after the procedures. It stops bleeding faster, improving clinician workflow, keeping patients safer, and allowing procedure rooms to be turned around faster. fixed-data-table